You are here

Article info

Article menu

Download PDFPDF

XML
Commentary
Immunogenicity of cell death driven by immune effectors

Authors

  • Lorenzo Galluzzi Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA Sandra and Edward Meyer Cancer Center, New York, NY, United States Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States Department of Dermatology, Yale School of Medicine, New Haven, CT, United States Université de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Giulia Petroni Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA PubMed articlesGoogle scholar articles
  • Guido Kroemer Université de Paris, Paris, France Equipe labellisée par la Ligue contre le cancer, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou, China Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lorenzo Galluzzi; deadoc80{at}gmail.com; Guido Kroemer; kroemer{at}orange.fr
View Full Text

Citation

Galluzzi L, Petroni G, Kroemer G
Immunogenicity of cell death driven by immune effectors
Journal for ImmunoTherapy of Cancer 2020;8:e000802. doi: 10.1136/jitc-2020-000802

Publication history

  • Accepted March 21, 2020
  • First published April 5, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.